No Data
Eli Lilly & Co (LLY) Gets a Buy From Jefferies
Technology stocks have become the market leader! Will the Pioneer Growth ETF outperform the s&p 500 again in 2025?
The Vanguard Growth etf has a strong record of outperforming the s&p 500, having surpassed this index on average every year since its establishment in 2004.
Why Is Eli Lilly and Company (LLY) Among Louis Navellier's Top Stock Picks Heading Into 2025?
The strongest competitor's data is not good, will the 'weight-loss duo' continue to dominate?
Analysts believe that if Amgen's weight loss drug could achieve a 20% weight loss effect a few years ago, it would have been the best among similar products, but now Eli Lilly and Co and Novo-Nordisk A/S pipeline drugs may achieve or exceed a 25% weight loss effect. Currently, dozens of pharmaceutical companies are actively entering the weight loss drug market, but none have shown the potential to truly challenge the 'weight loss giants'.
Eli Lilly and Novo Nordisk's Obesity Moat Just Got Stronger -- Heard on the Street -- WSJ
S&P 500 Posts Weekly Rise to Fresh Record, Ends November With Strongest Monthly Gain of Year